首页> 外文会议>World biomaterials congress >Non-cultured adipose-derived cells promote the bone augmentation induced by low-dose BMP2
【24h】

Non-cultured adipose-derived cells promote the bone augmentation induced by low-dose BMP2

机译:未经培养的脂肪来源的细胞可促进低剂量BMP2诱导的骨质增生

获取原文

摘要

BMP2 has been shown to induce bone formation in a variety of indications on bone engineering, and is now recognized as one of most effective materials that can confer osteolnducibility to bone substitutes. However, direct implantation of high doses of BMP2 is known to induce substantial swelling that may cause the obstruction of airway when applied to oral and cervical areas. On the other hand, recent studies have shown adipose-tissue contains on the order of 100- to 500-fold more MSCs than do bone-marrow after initial harvest Therefore, non-cultured adipose-derived cells (NC-ADCs) including high densities of stem/progenitor cells may possess a stronger bone regenerative capability and effectively reduce the amounts of 8MP2 required to induce bone formation. Our aim is to investigate whether NC-ADCs can promote the bone augmentation induced by low-dose BMP2. For experiments, human ADCs were isolated by enzymatically dissociation after surgical removal of buccal fat-pad. Then, NC-ADCs were obtained after centrifugation to separate the mature adipocytes. After characteristics analyses in vitro, 3×106 NC-ADCs were mixed with β-TCP granules that absorbed low-dose BMP2. and were transplanted to onlay-placement on mice cranium. Other four groups were transplanted as experimental controls. After 2 and 4 weeks, the specimens were harvested and observed histologically. As findings, remarkable augmented bone-area were observed at 2 weeks of transplantation when NC-ADCs were transplanted with low-dose BMP2. Furthermore, ectopic bone formation could be clearly recognized in those specimens at 4 weeks. This suggests NC-ADCs can facilitate the clinical use of BMP2 for bone engineering.
机译:BMP2已被证明可以在骨骼工程的各种适应症中诱导骨骼形成,现在已被认为是BMP2可以赋予骨替代品以骨诱导性的最有效材料之一。但是,已知直接植入高剂量的BMP2会引起明显的肿胀,当应用于口腔和宫颈区域时,可能会导致气道阻塞。另一方面,最近的研究表明,与最初收获后的骨髓相比,脂肪组织中所含的MSC比骨髓多100到500倍左右。因此,包括高密度的非培养脂肪来源细胞(NC-ADC)干细胞/祖细胞可能具有更强的骨再生能力,并有效减少诱导骨形成所需的8MP2量。我们的目的是研究NC-ADC是否可以促进低剂量BMP2诱导的骨质增生。为了进行实验,在手术切除颊脂肪垫后,通过酶解法分离了人类ADC。然后,离心后获得NC-ADC以分离成熟的脂肪细胞。经过体外特性分析后,将3×106 NC-ADC与吸收低剂量BMP2的β-TCP颗粒混合。并移植到小鼠颅骨上。将其他四组移植为实验对照。 2和4周后,收集标本并进行组织学观察。结果发现,当用低剂量BMP2移植NC-ADC时,在移植2周时观察到了明显的骨面积增大。此外,在第4周时在那些标本中可以清楚地识别出异位骨形成。这表明NC-ADC可以促进BMP2在骨工程中的临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号